Comparision of Efficacy and Safety of Orlistat vs Placebo in Obese Patients in Pakistan

Syed, Asghar Hussain; Meraj, Areeba; Bhandari, Laxman; Khan, Faria; Shaikh, Anam; Baig, Kanza; Kumar, Besham

doi:10.7759/cureus.9775

Cureus

2020

DOI: 10.7759/cureus.9775

|View full text |Cite

Comparision of Efficacy and Safety of Orlistat vs Placebo in Obese Patients in Pakistan

Asghar Hussain Syed

Areeba Meraj

Laxman Bhandari

et al.

Abstract: Open Access Original Article

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

A systematic review, ANCOVA meta-analysis, and meta-regression of clinical trials : Orlistat and body mass index of overweight and obese patients

Salim,

Tandy,

Puspitasari

2024

Mediterranean Journal of Nutrition and Metabolism

View full text Add to dashboard Cite

Background: Obesity or overfat (i.e., excessive fat accumulation in the host) contributes to cerebrocardiovascular and other diseases. Orlistat is a good obesity medication, unlike other drugs that have higher cardiac toxicity. It reversibly inhibits pancreatic and gastric lipases, and improves oxysterol metabolism. This study summarizes and elaborates the impact of orlistat on BMI in overweight and obese adult patients. Methods: All authors systematically searched and retrieved 288 controlled trial articles on orlistat and BMI from three databases, two registries, and citation searches using specific keywords. The quality and bias risks were determined by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE), Risk of Bias in Non-Randomized Study (ROBINS-I), and modified Jadad scale. R version 4.2.2 software calculated the effect size and the analysis of covariance (ANCOVA) effect, and subsequently analyzed using metafor. Results: This novel meta-analysis included 114 studies with 24,600 overweight or obese participants. We showed that orlistat substantially reduced BMI (mean difference −0.78 [−0.94, −0.63], p < 0.0001; I2 = 90.19%, pheterogeneity < 0.0001). Similarly, meta-regression showed a significant impact of orlistat daily dose (ß = −0.0019), yet not for duration (ß = −0.0024) and location (ß = −0.8591, −0.0190). Conclusion: Orlistat has the capacity to reduce BMI in overweight and obese individuals. Medical practitioners shall prescribe orlistat as a BMI lowering agent to complement other intervention in those patients

show abstract

A systematic review, ANCOVA meta-analysis, and meta-regression of clinical trials : Orlistat and body mass index of overweight and obese patients

Salim,

Tandy,

Puspitasari

2024

Mediterranean Journal of Nutrition and Metabolism

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Comparision of Efficacy and Safety of Orlistat vs Placebo in Obese Patients in Pakistan

Abstract: Open Access Original Article

Cited by 1 publication

References 10 publications

A systematic review, ANCOVA meta-analysis, and meta-regression of clinical trials : Orlistat and body mass index of overweight and obese patients

A systematic review, ANCOVA meta-analysis, and meta-regression of clinical trials : Orlistat and body mass index of overweight and obese patients

Contact Info

Product

Resources

About